Investors

Corporate Presentation

News Room

PATHWAY HEALTH CORP. ANNOUNCES FINAL EXCHANGE BULLETIN AND COMMENCEMENT OF TRADING

Etobicoke, Ontario, June 15, 2021 – Pathway Health Corp. (TSXV: PHC) (formerly Colson Capital Corp.) (“Pathway” or the “Company“) is pleased to announce that the …

Read More →

PATHWAY HEALTH CORP. ANNOUNCES OPTION GRANTS

Toronto, Ontario, June 9, 2021 – Pathway Health Corp. (TSXV: PHC) (formerly Colson Capital Corp.) (“Pathway” or the “Company”) announces that the Company’s board of …

Read More →

Pathway Health Corp. Announces TSXV Conditional Approval and Filing Statement for its Qualifying Transaction with Colson Capital and Closing of Qualifying Transaction

TORONTO, June 1, 2021 /CNW/ – Pathway Health Corp. (TSXV: PHC) (formerly Colson Capital Corp.) (“Pathway” or the “Company“) is pleased to announce that it has received conditional approval …

Read More →

Pathway Health Corp. and Colson Capital Corp. Announce Closing of $13.8 Million Financing

TORONTO, March 16, 2021 /CNW/ – Pathway Health, Corp. (“Pathway” or the “Company“), a subsidiary of The Clinic Network Canada Inc., and Colson Capital Corp. (TSXV: COLSP) (“Colson“), …

Read More →

Pathway Health Corp. and Geocann Form Strategic Partnership to Supply VESIsorb® Formulated Medical Cannabis Products to Leading Retail Pharmacy Brands throughout Canada

The partnership will allow Pathway Health to have exclusive distribution of a robust portfolio of proprietary formulations that are co-branded through its retail pharmacy partners …

Read More →

Pathway Health Announces Research Collaboration with Tilray

TORONTO, Feb. 17, 2021 – Pathway Health Corp. (“Pathway” or the “Company“) is pleased to announce a research collaboration with Tilray Canada Ltd, a subsidiary …

Read More →

Investor Inquiries

Investor Relations

Dave Burwell, Vice President
The Howard Group
(888) 221-0915  |  (403) 221-0915

investors@pathwayhealth.ca

Scroll to Top